Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4202 Preliminary experience with a new institutional dedicated neuroendocrine team in a tertiary

Introduction: Due to the complexity of neuroendocrine neoplasm (NEN) management, a multidisciplinary approach is strongly encouraged. At our institution, tertiary care center, a NEN Team was established in January 2021.

Conference:

Presenting Author: Smiroldo V

Authors: Smiroldo V, Bollina R, de Nucci G, Della Torre S,

Keywords: tertiary care center, multidisciplinary, NEN team,

#4193 Pivotal role of the multidisciplinary tumor board on the management of neuroendocrine neoplasms – Impact of MTB decisions in an ENETS Center of Excellence

Introduction: Multidisciplinary Tumor Board (MTB) meetings are a valuable tool to improve the management of solid tumors. Yet, few evidences regarding the real-world impact of Neuroendocrine Neoplasm (NEN)-dedicated MTBs are available.

Conference:

Presenting Author:

Authors: Maratta M, Vitale A, Occhipinti D, Raia S, Menotti S,

Keywords: multidisciplinary tumor board, neuroendocrine cancer, disease management, patient care,

#4050 PET/CT imaging of the somatostatin receptor with [18F]AlF-NOTA-octreotide PET/CT: Analysis of impact on tumor staging and therapeutic management

Introduction: [18F]AlF-NOTA-octreotide ([18F]AlF-OC) is a promising alternative for [68Ga]Ga-DOTA-somatostatin analogues (SSAs) in PET imaging of the somatostatin receptor (SST).

Conference:

Presenting Author: Leupe H

Authors: Leupe H, Vandamme T, van den Broeck B, Lybaert W, Dekervel J,

Keywords: Neuroendocrine tumor, nuclear medicine, PET imaging, somatostatin receptor, [68Ga]Ga-DOTA-SSA, [18F]AlF-NOTA-octreotide,

#3846 Poorly differentiated neuroendocrine carcinomas – Characteristics, treatments and outcomes from a population-based cohort discussed in our ENETS-CoE institute

Introduction: Poorly differentiated neuroendocrine carcinomas (NECs) are rare malignancies with a dismal prognosis, few therapeutic options available and lacking predictive factors.

Conference:

Presenting Author: Benini L

Authors: Benini L, Spada F, Gervaso L, Borghesani M, Rubino M,

Keywords: Neuroendocrine Carcinoma, NEC,

#3564 Prevalence of other malignant cancers in patients with neuroendocrine neoplasms

Introduction: Neuroendocrine neoplasms (NNE) are a heterogeneous group, arising from different anatomical locations. Studies showed a higher prevalence of other malignancies associated with NNE when compared to other types of cancer.

Conference:

Presenting Author: Amorim Costa C

Authors: Amorim Costa C, Peixoto M, Rebordão Pires M, Cruz Monteiro J, Elvas A,

Keywords: Neuroendocrine neoplasm, solid malignancies, hematological malignancies, screening,